raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:100985

Autosomal dominant spastic paraplegia type 4

Synonyms: SPG4

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adolescent, Adult, Childhood, Infancy
Status
active

A rare form of hereditary spastic paraplegia with high intrafamilial clinical variability, characterized in most cases as a pure phenotype with an adult onset (mainly the 3rd to 5th decade of life, but that can present at any age) of progressive gait impairment due to bilateral lower-limb spasticity and weakness as well as very mild proximal weakness and urinary urgency. In some cases, a complex phenotype is also reported with additional manifestations including cognitive impairment, cerebellar ataxia, epilepsy and neuropathy. A faster disease progression is noted in patients with a later age of onset.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutosomal dominant spastic paraplegia type 4SPG4
frParaplégie spastique autosomique dominante type 4= en
deSpastische Paraplegie, autosomal-dominante, Typ 4SPG4 · Spastische Paraplegie, autosomal-dominante, familiäre, Typ 2
esParaplejía espástica autosómica dominante tipo 4= en
itParaplegia spastica autosomica dominante, tipo 4Paraplegia spastica autosomica dominante, tipo 2 · SPG4
nlAutosomaal dominante spastische paraplegie type 4= en
ptParaplegia espástica autossómica dominante tipo 4= en
plAutosomalna dominująca paraplegia spastyczna typu 4= en
csAutozomálně dominantní spastická paraplegie, typ 4= en
ukАутосомно-домінантна спастична параплегія, тип 4= en
zh常染色体显性遗传痉挛性截瘫4型= en
trOtozomal dominant spastik parapleji tip 4= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM182601Evalidated
ICD-10G11.4NTBTattributedvalidated
ICD-118B44.00NTBTindexvalidated
MONDO0008438Evalidated
MeSHC536865Evalidated
UMLSC1866855Evalidated
GARD4925Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
SPASTDisease-causing germline mutation(s) inAssessedHGNC:11233ENSG000000215746042772p22.3spastin17895902[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 1 000 0000.91 / 100 000PortugalValue and classValidated23609960[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

19 annotations · validated 2018-03-02
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0011448Ankle clonus
HP:0003487Babinski sign
HP:0001348Brisk reflexes
HP:0004302Functional motor deficit
HP:0006938Impaired vibration sensation at ankles
HP:0008969Leg muscle stiffness
HP:0007340Lower limb muscle weakness
HP:0002061Lower limb spasticity
HP:0001257Spasticity
HP:0000012Urinary urgency
Occasional (29-5%)
HP:0100543Cognitive impairment
HP:0003693Distal amyotrophy
HP:0001260Dysarthria
HP:0007350Hyperreflexia in upper limbs
HP:0001761Pes cavus
HP:0002839Urinary bladder sphincter dysfunction
Very rare (<4-1%)
HP:0001251Ataxia
HP:0001249Intellectual disability
HP:0001250Seizure

Annotation source: 20301339[PMID]_17098887[PMID]

7

Sources for this card